Blox Inc. BLXX (OTCMKTS:BLXX) makes easy gains off Lows

blxx
Blox Inc (OTCMKTS:BLXX) has made nice gains today on record volume. Today BLXX traded from...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) is Attrac...
Inspira Technologies IINN is Up, Why is That? Take a...
PPCB Stock Price is down BIG, is it ready to BOUNCE?...

Blox Inc (OTCMKTS:BLXX) has made nice gains today on record volume. Today BLXX traded from $0.04 to highs of $0.09 and is currently sitting around $0.08 pos. 

Todays total $ volume is just under $40,000.00 but even that is more than its traded in a single day for more than a year. With little selling pressure todays gains of 70% could just be the beginning of a nice move back to prices around $0.35 and needless to say its not going to take much volume to really move BLXX.

blxx

If less than $40,000 in trade value can move BLXX 70%

BLXX could really have some potential over the near future and we will continue to be watching and updating our subscribers.

Business Description

Blox Inc. (“Blox”), is a publicly traded Resource Exploration and Development Company.

Blox Inc. is focused on West Africa and at present has three Gold concessions in Ghana and one Gold concession in Guinea.

Blox Energy aims to green the mining process by implementing renewable energy into its own production processes and ultimately into those of other bulk power consumers in West Africa.

Blox’s shares trade on the OTCQB under the symbol BLXX.

Blox Inc. is based out of Vancouver B.C. Canada

blxx

http://www.otcmarkets.com/stock/BLXX/quote

Stay in the lopp :

Voce Capital is Buying Cutera Inc. (NASDAQ:CU...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cutera Inc. (NASDAQ:CUTR) reported that Voce Capital has picked up
Dais Corp DLYT up over 2,000%

Company Name: Dais Corporation 

Ticker: (DLYT)

Exchange: OTC

Website: https://daisanalytic.com/

Company

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) is...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) reported that Genesis Capital Advisors Llc.

related post

Skip to content